Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.48 USD | -0.29% | -.--% | -.--% |
2023 | EV Biologics, Inc. Closes A $500,000 Interest-Free Loan | CI |
2023 | Ev Biologics Completes Production of Cutting-Edge Msc Exosome-Based Therapeutic | CI |
Sales 2016 | 4.26Cr 355.88Cr | Sales 2017 | 95.07L 79Cr | Capitalization | 60.95L 51Cr |
---|---|---|---|---|---|
Net income 2016 | -5.3Cr -442.31Cr | Net income 2017 | -70L -58Cr | EV / Sales 2016 | 0.69 x |
Net Debt 2016 | 89.96L 75Cr | Net Debt 2017 | 1Cr 84Cr | EV / Sales 2017 | 1.7 x |
P/E ratio 2016 |
-0.38
x | P/E ratio 2017 |
-0.82
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 23.58% |
1 day | -0.29% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel McKinney
CEO | Chief Executive Officer | 62 | 29/18/29 |
Jason Sanders
BRD | Director/Board Member | 46 | 31/20/31 |
William Bossung
BRD | Director/Board Member | - | 07/23/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel McKinney
CEO | Chief Executive Officer | 62 | 29/18/29 |
William Bossung
BRD | Director/Board Member | - | 03/18/03 |
Jason Sanders
BRD | Director/Board Member | 46 | 31/20/31 |
1st Jan change | Capi. | |
---|---|---|
+20.30% | 4.94TCr | |
+16.96% | 1.66TCr | |
-0.14% | 1.58TCr | |
-10.36% | 1.12TCr | |
+35.06% | 943.76Cr | |
+44.08% | 792.61Cr | |
-4.45% | 780.37Cr | |
-5.09% | 760.55Cr | |
+105.28% | 724Cr |
- Stock Market
- Equities
- YECO Stock
- YECO Stock